Prosecution Insights
Last updated: November 04, 2026
Application No. 18/638,080

CANNULA ASSEMBLY SYSTEMS AND METHODS

Non-Final OA §102§103§112
Filed
Apr 17, 2024
Priority
Apr 18, 2023 — provisional 63/460,215
Examiner
HARRIS, WESLEY G
Art Unit
3783
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Revelle Aesthetics Inc.
OA Round
1 (Non-Final)
74%
Grant Probability
Favorable
1-2
OA Rounds
0m
Est. Remaining
95%
With Interview

Examiner Intelligence

Grants 74% — above average
74%
Career Allowance Rate
545 granted / 741 resolved
+3.5% vs TC avg
Strong +22% interview lift
Without
With
+21.6%
Interview Lift
resolved cases with interview
Typical timeline
2y 6m
Avg Prosecution
41 currently pending
Career history
800
Total Applications
across all art units

Statute-Specific Performance

§101
1.8%
-38.2% vs TC avg
§103
36.8%
-3.2% vs TC avg
§102
22.9%
-17.1% vs TC avg
§112
36.4%
-3.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 741 resolved cases

Office Action

§102 §103 §112
DETAILED ACTION The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claim 8 is rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Regarding claim 8: The claim recites the limitation "the controller" in line 2. There is insufficient antecedent basis for this limitation in the claim. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale or otherwise available to the public before the effective filing date of the claimed invention. Claims 1, 3, 6, 8, 10, 11, 13 and 14 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by US 5242386 A to Holzer. Holzer discloses: Regarding claim 1: An aesthetic treatment system (figure 1), comprising: a cannula assembly (10) defining an elongate profile (see elongate profile of 10 as shown in figure 1) and having a proximal end portion (see the proximal end portion B in figure 1 below) and a distal end portion (see the distal end portion A in figure 1 below), the cannula assembly (10) being configured to inject or collect fat (“liposuction”; column 4, lines 5-15); and an ultrasound transducer (40) configured at the distal end portion (A in figure 1 below) (as shown in figure 1 below). PNG media_image1.png 708 440 media_image1.png Greyscale Figure 1 - figure 1 of Holzer, annotated by the examiner Regarding claim 3: The aesthetic treatment system of claim 1, wherein the ultrasound transducer (40) is configured to send and receive an ultrasound energy (column 3, lines 32-50), wherein the system is configured to analyze the ultrasound energy to assess a depth of the cannula assembly (10) within tissue (analyzed by the “pulse-processing circuit” and the “computer video screen” mentioned in column 3, lines 32-60). Regarding claim 6: The aesthetic treatment system of claim 1, further comprising a controller (see the “pulse-processing circuit” and the “computer video screen” mentioned in column 3, lines 32-60) configured to process ultrasound energy information (column 3, lines 32-60). Regarding claim 8: The aesthetic treatment system of claim 1, further comprising a display (“computer video screen” mentioned in column 4, lines 32-60), wherein the controller is configured to process and present ultrasound energy information (determines the position of the canula based on the ultrasound as indicated in column 4, lines 4-7) or light energy information on the display. Regarding claim 10: The aesthetic treatment system of claim 1, wherein a highly comprehensive or a full ultrasonic image is presented on a display (visual control as indicated in column 4, lines 4-7). Regarding claim 11: The aesthetic treatment system of claim 1, wherein a digital display is employed to provide depth information (video screen indicates if the tip 32 of the cannula is below the “muscle fascia” as indicated in column 4, lines 4-7). Regarding claim 13: The aesthetic treatment system of claim 1, further comprising a standard cannula (10) and a sleeve (20) including depth assessment structure (see the end of sleeve 20 at location C as shown in figure 1 above which indicates the depth of the cannula) and functionality and being sized and shaped to engage and attach to the standard cannula (as shown in figure 1). Regarding claim 14: The aesthetic treatment system of claim 1, wherein the cannula assembly (10) is steerable (can be positioned to perform liposuction column 4, lines 1-10). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 2, 4-5, 7 and 12 is/are rejected under 35 U.S.C. 103 as being unpatentable over US 5242386 A to Holzer as applied to claim 1 above, and further in view of WO 2021150479 A1 to Podmore et al. (Podmore). Regarding claim 2: Holzer fails to disclose: The aesthetic treatment system of claim 1 further comprising: a light emitter configured at the distal end portion. Podmore teaches: A aesthetic treatment system (figures 8a-8d; liposuction as indicated in ¶0005) that includes a cannula (554 om figure 6a) that includes two LED light sources (656 and 652; ¶0071). The light sources aid in determining the depth of the cannula (¶0071). Further. The lights sources can emit different colors (¶0071). Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify Holzer to further include multiple light emitters (a light emitter) at the distal end of the cannula as taught by Podmore to aid in determining the depth of the cannula (Podmore, ¶0071). Regarding claim 4: All limitations of the claim are taught by the 35 USC 103 rejection of claim 2 by Holzer and Podmore: The aesthetic treatment system of claim 2, wherein the light emitter is configured to provide transillumination for tracking the cannula assembly within tissue (the light from the LED’s incorporated from Podmore into Holzer allows for the location and depth of the cannula to be determined). Regarding claim 5: All limitations of the claim are taught by the 35 USC 103 rejection of claim 2 by Holzer and Podmore: The aesthetic treatment system of claim 2, wherein the light emitter is configured to provide depth information of the cannula assembly within tissue (the light from the LED’s incorporated from Podmore into Holzer allows for the location and depth of the cannula to be determined). Regarding claim 7: Holzer fails to disclose: The aesthetic treatment system of claim 1, further comprising a controller configured to process light energy information. Podmore teaches: A aesthetic treatment system (figure 5; liposuction as indicated in ¶0005) that includes a cannula (506 om figure 5) that includes markings. The system further includes an optical encoder (processes light) that reads the markings in determining the depth of the cannula (¶0064). Further a controller (504) process the light energy information from the encoder (¶0064). Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify Holzer to further include markings on the cannula, an optical encoder and controller as taught by Podmore in order to determine the depth of the cannula (Podmore, ¶0064). This would add a controller configured to process light energy (light energy received by the encoder and information passed to the controller). Regarding claim 12: All limitations of the claim are taught by the 35 USC 103 rejection of claim 2 by Holzer and Podmore: The aesthetic treatment system of claim 1, further comprising an LED (see the LED’s incorporated from Podmore into Holzer) that flashes or changes color to represent a depth of the cannula assembly (see how the color or the overlapping color of the multiple LED’s indicates the depth of the cannula as indicated in ¶0071 of Podmore which would be incorporated into Holzer to operate in the same manner to determine depth). Claim(s) 9 is/are rejected under 35 U.S.C. 103 as being unpatentable over US 5242386 A to Holzer as applied to claim 1 above, and further in view of US 4936281 A to Stasz. Regarding claim 9: Holzer fails to disclose: The aesthetic treatment system of claim 1, wherein A-scans are presented on a display. Stasz teaches: A cannula assembly (figure 1) that includes a cannula (10) to remove material form the body (column 1, lines 6-11). Further, the system uses A-scans to direct the position of the tip of the cannula (column 4, lines 40-51). Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify Holzer to further include A-scans on the display as taught by Stasz to determine the position of the cannula distal tip (Stasz, column 4, lines 40-51). Claim(s) 15 is/are rejected under 35 U.S.C. 103 as being unpatentable over US 5242386 A to Holzer as applied to claim 1 above, and further in view of US 20070276352 A1 to Crocker et al. (Crocker). Regarding claim 15: Holzer fails to disclose: The aesthetic treatment system of claim 1, wherein the cannula assembly is longitudinally flexible. Crocker teaches: An aesthetic treatment system (figure 1) that can be used for liposuction (¶0114). The system can include a cannula (105) that can be flexible (¶0114) for use with a child. Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the cannula in Holzer to a flexible cannula as taught by Crocker for use with a child to operate in more confined spaces (Crocker, ¶0114). Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. The following is pertinent prior art: US-20100168570-A1 Sliwa See the ultrasound assembly 22 US-5636644-A Hart See the ultrasound assembly 85 US-20140336477-A1 McGee See the ultrasound assembly 38/40 US-20070043344-A1 McAuley See the ultrasound assembly 256 AU-2007254588-A1 ANDERSON See the ultrasound assembly 220 WO-9817185-A1 NEGUS See the ultrasound assembly 162 WO-0105318-A1 UTLEY See the ultrasound assembly 74 Any inquiry concerning this communication or earlier communications from the examiner should be directed to WESLEY HARRIS whose telephone number is (571)272-3665. The examiner can normally be reached M to F, 9am-5pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Michael Tsai can be reached on (571) 270-5246. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /WESLEY G HARRIS/Examiner, Art Unit 3783
Read full office action

Prosecution Timeline

Apr 17, 2024
Application Filed
Aug 18, 2026
Non-Final Rejection mailed — §102, §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12779132
NEEDLE SHIELD REMOVER AND A MEDICAMENT DELIVERY DEVICE COMPRISING THE NEEDLE SHIELD REMOVER
2y 11m to grant Granted Nov 03, 2026
Patent 12773237
Surgical Instrument
3y 3m to grant Granted Oct 27, 2026
Patent 12773488
OPHTHALMIC SURGICAL CASSETTE
2y 3m to grant Granted Oct 27, 2026
Patent 12766248
DISPENSING DEVICE FOR WEARABLE DRUG DELIVERY DEVICE
4y 6m to grant Granted Oct 20, 2026
Patent 12765871
TREATMENT TOOL FOR ENDOSCOPE
3y 11m to grant Granted Oct 20, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
74%
Grant Probability
95%
With Interview (+21.6%)
2y 6m (~0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 741 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month